FTC Asks AbbVie, Others For Deal Docs In Pay-For-Delay Suit
The Federal Trade Commission and private plaintiffs suing AbbVie Products LLC and other drugmakers over patent pay-for-delay settlements for testosterone drug AndroGel moved Friday to force the companies to turn over...To view the full article, register now.
Already a subscriber? Click here to view full article